Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG

Dr Roger Li - Moffitt Cancer Center, Tampa, USA

CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG ( Dr Roger Li - Moffitt Cancer Center, Tampa, USA )

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti...

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )

Quality management in breast surgery

Dr Didier Verhoeven, Prof P.G. Roy and Dr Terry Sarantou

Quality management in breast surgery ( Dr Didier Verhoeven, Prof P.G. Roy and Dr Terry Sarantou )

SG monotherapy demonstrates a high response rate in PT-ineligible patients with...

Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA

SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )

Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows...

Dr Daniel Geynisman - Fox Chase Cancer Center, Pennsylvania, USA

Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC ( Dr Daniel Geynisman - Fox Chase Cancer Center, Pennsylvania, USA )

ASCO GU 2023: Latest updates in mRCC

Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor...

ASCO GU 2023: Latest updates in mRCC ( Dr Javier Puente, Dr Bernard Escudier, Prof Stéphane Oudard, Prof Viktor Grünwald and Prof Toni Choueiri )

Nivolumab and salvage nivolumab plus ipilimumab for aRCC

Prof Michael Atkins - Georgetown Lombardi Comprehensive Cancer Center...

Nivolumab and salvage nivolumab plus ipilimumab for aRCC ( Prof Michael Atkins - Georgetown Lombardi Comprehensive Cancer Center, Georgetown, USA )

Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous...

Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA

Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous cell carcinoma ( Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA )

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )

Management of HER2 positive metastatic breast cancer treatment algorithm

Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA

Management of HER2 positive metastatic breast cancer treatment algorithm ( Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA )

Immuno-radiotherapy: rationale and new perspectives for breast cancer patients

Prof Roberto Orecchia - University of Milan, Milan, Italy

Immuno-radiotherapy: rationale and new perspectives for breast cancer patients ( Prof Roberto Orecchia - University of Milan, Milan, Italy )

Post neoadjuvant management in BRCA mutant breast cancer patients

Prof Banu Arun - MD Anderson Cancer Center, Houston, USA

Post neoadjuvant management in BRCA mutant breast cancer patients ( Prof Banu Arun - MD Anderson Cancer Center, Houston, USA )

More from ecancer